Ground-Breaking Electroporation-based Intervention for PAROXysmal Atrial Fibrillation Treatment (BEAT PAROX-AF)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 292 participants.

Also called NCT05159492

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 292 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05159492
Other papers using this trial's data
  • Pulsed field vs radiofrequency ablation for paroxysmal atrial fibrillation: the BEAT PAROX-AF trial European heart journal, 2026-04-01 DOI, PubMed 41568658, PMC13043192 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Austria, Belgium, Czechia, France, Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05159492. Randomized; single masking; primary purpose treatment. Start 2021-12-27 (actual); primary completion 2025-02-14 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ground-Breaking Electroporation-based Intervention for PAROXysmal Atrial Fibrillation Treatment (BEAT PAROX-AF)
Acronym
BEAT PAROX-AF
Intervention (Device)
PVI using PEF
Intervention (Device)
PVI using CFRF
Lead sponsor
University Hospital, Bordeaux (class: other)
Collaborator
Horizon 2020 - European Commission (class: other)

Record details

Record id
cardio:ct-nct05159492
Content hash
51e0e2c86320e50cf08b094120c078d0e2c702436cb130f3cb403ffc06329bf1